MetaCap

Clover Health Investments (CLOV) vs Fortrea (FTRE)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Fortrea (FTRE) has outperformed Clover Health Investments (CLOV) over the past year, gaining 70.2% versus a gain of 63.6%. Clover Health Investments is the larger company by market cap ($2.00 billion vs $1.79 billion), about 1.1 times the size. On valuation, Fortrea trades at a lower forward P/E (16.5x vs 20.7x for Clover Health Investments).

Clover Health Investments converts more of its revenue into profit, with a net margin of -4.4% versus -36.2%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CLOV+63.60%FTRE+70.18%
+146%+56%-34%
Nov 21, 20251 yearNov 20, 2026
CLOV+313.53%FTRE-38.37%
+529%+207%-116%
Jun 12, 20235 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CLOV versus FTRE key metrics
MetricCLOVFTRE
Share price$3.73$18.55
Market cap$2.00B$1.79B
1-day change-1.06%-7.94%
YTD return+58.72%+7.54%
1-year return+63.60%+70.18%
5-year return-31.05%—
P/E ratio (TTM)373.00—
Forward P/E20.7216.52
EPS (TTM)$0.01$-0.73
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$1.92B$2.72B
Revenue growth (YoY)+40.34%+1.00%
Net income (latest FY)$-85.55M$-986.20M
Gross margin—18.50%
Operating margin-4.44%-32.04%
Net margin-4.45%-36.21%
52-week high$5.59$26.16
52-week low$1.58$8.55
Distance from 52-week high-33.27%-29.09%
Analyst consensusbuybuy
Avg. price target upside+50.13%+27.39%
Average volume4.49M1.69M
Shares outstanding439.71M96.50M
Employees72414,000
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Clover Health Investments is more profitable, keeping -4.4 cents of every revenue dollar as net income versus -36.2 cents for Fortrea.
  • Clover Health Investments grew revenue faster in its latest fiscal year (+40.34% vs +1.00%).

About Clover Health Investments

CLOV stock →

Clover Health Investments, Corp. provides medicare advantage plans in the United States.

Health Care · Medical Specialities · 724 employees

About Fortrea

FTRE stock →

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services.

Health Care · Medical Specialities · 14,000 employees

CLOV vs FTRE FAQ

Which is bigger, Clover Health Investments or Fortrea?

Clover Health Investments (CLOV) is larger, with a market capitalization of $2.00B compared with $1.79B for Fortrea (FTRE).

Which stock has performed better over the past year, CLOV or FTRE?

FTRE returned +70.18% over the past 12 months, compared with +63.60% for CLOV (price return, excluding dividends). Past performance does not predict future results.

Are Clover Health Investments and Fortrea in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons